The Molecular Tumor Board Turns 10: The Age of Complexity
Adam Wahida1, Razelle Kurzrock2,3
1Institute of Metabolism and Cell Death, Helmholtz Centre Munich, Neuherberg, Germany.
The Oncologist
|October 17, 2024
Abstract:
Gene sequencing has brought a titanic of complex data into clinical precision oncology. Deciphering this complexity for practice requires new constructs. In 2014, the Molecular Tumor Board (MTB) was introduced into the literature by a publication in The Oncologist. Ten years later, MTBs have become globally established vehicles that integrate rapidly emerging "omic" information, helping to transform cancer management.


